Characteristics | DS-TB | MDR-TB | All |
---|---|---|---|
n = 752 | n = 25 | n = 777 | |
Gender, n (%) | |||
Female | 285 (37.9) | 4 (16.0) | 289 (37.2) |
Male | 467 (62.1) | 21 (84.0) | 488 (62.8) |
Age in years, mean (SD) | 39.5 (18.9) | 42.5 (14.9) | 39.6 (18.8) |
Treatment phase, n (%) | |||
Intensive | 292 (38.8) | 11 (44.0) | 303 (39.0) |
Continuation | 460 (61.2) | 14 (56.0) | 474 (61.0) |
Treatment history, n (%) | |||
New | 677 (90.0) | 17 (68.0) | 694 (89.3) |
Relapse/Retreatment | 75 (10.0) | 8 (32.0) | 83 (10.7) |
Treatment modality, n (%) | |||
Self-administration | 420 (55.8) | 12 (48.0) | 432 (55.6) |
Home-based DOT | 317 (42.2) | 3 (12.0) | 320 (41.2) |
Facility-based DOT | 15 (2.0) | 10 (40.0) | 25 (3.2) |
Treatment delay, n (%) | |||
> 4 weeks since start of symptoms | 86 (11.4) | 11 (44.0) | 94 (12.3) |
Patient's education status, n (%) | 591 | 20 | 611 |
No education | 4 (0.7) | 0 | 4 (0.7) |
Primary school | 444 (75.1) | 15 (75.0) | 459 (75.1) |
Secondary/high school | 121 (20.5) | 5 (25.0) | 126 (20.6) |
University and higher | 22 (3.7) | 0 | 22 (3.6) |
Employed before TB, n (%) | 622 (82.7) | 22 (88.0) | 644 (82.9) |
Employed after TB, n (%) | 278 (37.0) | 5 (20.0) | 283 (36.4) |